Total Payments
$12,716
2024 Payments
$1,756
Companies
48
Transactions
782
Medicare Patients
9,558
Medicare Billing
$828,809
Payment Breakdown by Category
Food & Beverage$12,267 (96.5%)
Education$448.91 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,267 | 765 | 96.5% |
| Education | $448.91 | 17 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $4,119 | 295 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,526 | 94 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,030 | 61 | $0 (2024) |
| Mylan Specialty L.P. | $685.41 | 41 | $0 (2024) |
| United Therapeutics Corporation | $567.07 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $512.63 | 23 | $0 (2024) |
| PFIZER INC. | $475.27 | 26 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $379.52 | 40 | $0 (2019) |
| CSL Behring | $318.53 | 10 | $0 (2018) |
| Insmed, Inc. | $290.51 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,756 | 85 | GlaxoSmithKline, LLC. ($434.53) |
| 2023 | $986.89 | 50 | GlaxoSmithKline, LLC. ($274.15) |
| 2022 | $853.00 | 51 | GlaxoSmithKline, LLC. ($363.96) |
| 2021 | $794.19 | 52 | GlaxoSmithKline, LLC. ($240.52) |
| 2020 | $1,465 | 95 | GlaxoSmithKline, LLC. ($621.63) |
| 2019 | $1,941 | 144 | GlaxoSmithKline, LLC. ($578.94) |
| 2018 | $2,578 | 164 | GlaxoSmithKline, LLC. ($958.68) |
| 2017 | $2,341 | 141 | GlaxoSmithKline, LLC. ($646.52) |
All Payment Transactions
782 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Immunology | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.67 | General |
| 10/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Cardio-pulmonary | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.90 | General |
| Category: Narcoplepsy | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,517 | 3,185 | $828,965 | $197,762 |
| 2022 | 12 | 2,438 | 3,319 | $770,435 | $220,120 |
| 2021 | 12 | 2,456 | 3,268 | $707,585 | $215,329 |
| 2020 | 14 | 2,147 | 2,937 | $673,413 | $195,598 |
Total Patients
9,558
Total Services
12,709
Medicare Billing
$828,809
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 867 | 1,416 | $248,280 | $89,779 | 36.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 60 | 61 | $99,308 | $29,934 | 30.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 188 | 188 | $61,130 | $22,873 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 238 | $56,360 | $22,465 | 39.9% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 118 | 123 | $135,300 | $13,667 | 10.1% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 246 | 272 | $40,800 | $7,456 | 18.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 59 | 70 | $5,600 | $2,613 | 46.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 246 | 259 | $31,080 | $2,399 | 7.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 250 | 263 | $69,695 | $2,091 | 3.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 251 | 264 | $45,408 | $1,818 | 4.0% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 14 | 14 | $17,304 | $1,606 | 9.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 17 | 17 | $18,700 | $1,059 | 5.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 966 | 1,720 | $247,000 | $113,311 | 45.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 72 | 73 | $118,844 | $37,284 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 198 | 198 | $59,400 | $25,328 | 42.6% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 100 | 101 | $111,100 | $12,740 | 11.5% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 333 | 417 | $62,550 | $12,132 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 112 | $21,040 | $10,642 | 50.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 203 | 212 | $25,440 | $2,049 | 8.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 205 | 215 | $56,975 | $1,785 | 3.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 23 | 24 | $26,400 | $1,715 | 6.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 208 | 218 | $37,496 | $1,571 | 4.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,750 | $824.64 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 18 | $1,440 | $738.04 | 51.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 1,021 | 1,749 | $227,370 | $116,696 | 51.3% |
About Dr. Robert Mcdonald, MD
Dr. Robert Mcdonald, MD is a Pulmonary Disease healthcare provider based in Carson City, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295807006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Mcdonald, MD has received a total of $12,716 in payments from pharmaceutical and medical device companies, with $1,756 received in 2024. These payments were reported across 782 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($12,267).
As a Medicare-enrolled provider, Mcdonald has provided services to 9,558 Medicare beneficiaries, totaling 12,709 services with total Medicare billing of $828,809. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Carson City, NV
- Active Since 11/15/2006
- Last Updated 03/07/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1295807006
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,439
- NUCALA (Biological) $1,409
- DUPIXENT (Biological) $688.16
- OFEV (Drug) $651.96
- BREO (Drug) $592.57
- ANORO (Drug) $552.29
- ORENITRAM (Drug) $438.19
- BEVESPI AEROSPHERE (Drug) $378.16
- STIOLTO RESPIMAT (Drug) $355.67
- Zemaira (Biological) $318.53
- YUPELRI (Drug) $317.03
- Arikayce (Drug) $290.51
- GLASSIA (Biological) $269.67
- CHANTIX (Drug) $261.99
- SPIRIVA RESPIMAT (Drug) $261.51
- SYMBICORT (Drug) $261.13
- STIOLTO (Drug) $246.79
- Yupelri (Drug) $226.86
- Esbriet (Biological) $214.22
- ELIQUIS (Drug) $176.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.